Research ArticleArticle
Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells
Melania Dovizio, Thorsten J. Maier, Sara Alberti, Luigia Di Francesco, Emanuela Marcantoni, Götz Münch, Constance M. John, Beatrix Suess, Alessandro Sgambato, Dieter Steinhilber and Paola Patrignani
Molecular Pharmacology July 2013, 84 (1) 25-40; DOI: https://doi.org/10.1124/mol.113.084988
Melania Dovizio
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Thorsten J. Maier
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Sara Alberti
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Luigia Di Francesco
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Emanuela Marcantoni
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Götz Münch
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Constance M. John
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Beatrix Suess
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Alessandro Sgambato
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Dieter Steinhilber
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)
Paola Patrignani
Department of Neuroscience and Imaging and Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy (M.D., S.A., L.D.F., E.M., P.P.); Institutes of Pharmaceutical Chemistry, Frankfurt University, Frankfurt, Germany (T.J.M., D.S.); CorImmun GmbH, Martinsried, Germany (G.M.); MandalMed, Inc., San Francisco, California (C.M.J.); Fachbereich Biologie, Technische Universität Darmstadt, Darmstadt, Germany (B.S.); and Institute of General Pathology, Catholic University, Rome, Italy (A.S.)

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Platelet-Tumor Cell Cross-Talk and Malignancy
Melania Dovizio, Thorsten J. Maier, Sara Alberti, Luigia Di Francesco, Emanuela Marcantoni, Götz Münch, Constance M. John, Beatrix Suess, Alessandro Sgambato, Dieter Steinhilber and Paola Patrignani
Molecular Pharmacology July 1, 2013, 84 (1) 25-40; DOI: https://doi.org/10.1124/mol.113.084988
Research ArticleArticle
Platelet-Tumor Cell Cross-Talk and Malignancy
Melania Dovizio, Thorsten J. Maier, Sara Alberti, Luigia Di Francesco, Emanuela Marcantoni, Götz Münch, Constance M. John, Beatrix Suess, Alessandro Sgambato, Dieter Steinhilber and Paola Patrignani
Molecular Pharmacology July 1, 2013, 84 (1) 25-40; DOI: https://doi.org/10.1124/mol.113.084988
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement